Physician profile
John L Burns
NPI 1881665289
$2,066.91
in general payments reported to CMS, 2019-2025
19 companies · $494 in 2025
The $494 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $132 · 2021: $194 · 2022: $111 · 2023: $655 · 2024: $380 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $258.65 | 2020-2025 | Precision 1, Total30 |
| Biotissue Holdings INC. | $252.58 | 2023 | |
| Dompe US, INC. | $212.59 | 2024 | Oxervate |
| New World Medical,INC. | $200.73 | 2023 | |
| Allergan, INC. | $166.64 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $140.87 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $140.63 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $124.72 | 2025 | Idosetr |
| Johnson & Johnson Vision Care, INC. | $114.51 | 2025 | Acuvue |
| Horizon Therapeutics Plc | $110.50 | 2022 | |
| Coopervision INC. | $101.91 | 2019-2024 | Misight Contact Lens, Onefit Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $57.12 | 2020-2021 | |
| Lkc Technologies, INC. | $45.45 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $39.18 | 2024 | Dupixent |
| Johnson & Johnson Surgical Vision, INC. | $30.16 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.05 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Plexus Optix, INC. | $17.57 | 2021 | |
| Visioneering Technologies, INC. | $13.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.